➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Merck
Dow
McKesson
Colorcon
McKinsey

Last Updated: September 23, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR EPIDUO

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

All Clinical Trials for Epiduo

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00757523 ↗ Evaluation of the Effectiveness, Safety, and Tolerability of Duac Akne Gel and Epiduo Gel in the Treatment of Facial Acne Vulgaris Completed GlaxoSmithKline Phase 4 2008-09-01 The purpose of this study is to compare the effectiveness of two marketed products in subjects with facial acne vulgaris
NCT00757523 ↗ Evaluation of the Effectiveness, Safety, and Tolerability of Duac Akne Gel and Epiduo Gel in the Treatment of Facial Acne Vulgaris Completed Stiefel, a GSK Company Phase 4 2008-09-01 The purpose of this study is to compare the effectiveness of two marketed products in subjects with facial acne vulgaris
NCT00907101 ↗ Evaluate Effectiveness of Epiduo┬« Gel in Reducing Antibiotic Sensitive & Resistant Strains of Propionibacterium (P)Acnes Completed Galderma Laboratories, L.P. Phase 4 2009-06-01 The purpose of this study is to evaluate the effectiveness of Epiduo┬« Gel in reducing antibiotic sensitive and resistant strains of P acnes in vivo.
NCT00919191 ↗ Evaluation of Irritation by Two Facial Gels Applied to Opposite Sides of the Face Completed Valeant Pharmaceuticals International, Inc. Phase 4 2009-04-01 A study to compare the skin irritation potential of two marketed gels for acne treatment, each applied to half of the face of healthy volunteers.
NCT00952523 ↗ Evaluation of Irritation That Potentially Could be Caused by Two Facial Gels Applied to Opposite Sides of the Face Completed Valeant Pharmaceuticals International, Inc. Phase 4 2009-07-01 A study to compare the skin irritation potential of two marketed gels for acne treatment, each applied to half of the face of healthy volunteers.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Epiduo

Condition Name

Condition Name for Epiduo
Intervention Trials
Acne Vulgaris 19
Acne 8
Local Adverse Effects 1
Facial Acne 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Epiduo
Intervention Trials
Acne Vulgaris 20
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Epiduo

Trials by Country

Trials by Country for Epiduo
Location Trials
United States 60
Canada 7
India 5
Germany 3
Poland 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Epiduo
Location Trials
Texas 5
Florida 5
North Carolina 4
California 4
Pennsylvania 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Epiduo

Clinical Trial Phase

Clinical Trial Phase for Epiduo
Clinical Trial Phase Trials
Phase 4 12
Phase 3 5
Phase 2 2
[disabled in preview] 9
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Epiduo
Clinical Trial Phase Trials
Completed 20
Not yet recruiting 3
Recruiting 2
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Epiduo

Sponsor Name

Sponsor Name for Epiduo
Sponsor Trials
Galderma 5
Galderma Laboratories, L.P. 5
Galderma Laboratorium GmbH 3
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Epiduo
Sponsor Trials
Industry 25
Other 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
McKinsey
Harvard Business School
AstraZeneca
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.